Zeinab Hosseinidoust

Associate Professor, Chemical Engineering

0000-0001-9261-7611

I am a chemical and biomedical engineer and the Canada Research Chair in Bacteriophage Bioengineering. My mission is to create innovative technologies that disrupt and revitalize the antimicrobial industry and advance the global battle against superbugs. Antibiotics have broadly been used across industries as a reliable method of biocontrol since their discovery in the mid 20th century. Despite their widespread adoption and success, their efficacy is beginning to wane due to the emergence of antimicrobial resistance. Bacteriophages are viruses exclusive to bacteria that offer a highly targeted antibacterial action. Despite the strong body of evidence supporting phage as an effective antimicrobial, the field suffers from a paucity of technologies that support the safe, effective, and economical use of phage in real life scenarios.
We use engineering principals of design and analysis to develop transformative technologies that bridge the gap between phage biology and real world applications, ultimately making phage antimicrobials more accessible and preparing our world for a post antibiotic era. We have developed a diverse portfolio of intellectual property (IP), built around impactful scientific publications, supporting the application of bacteriophage biomaterials across industrial, agricultural, and clinical fields. You can learn more about our research platforms and active research projects on our lab website: Hosseinidoustlab.com